These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28808948)

  • 1. Tiotropium Bromide in Children and Adolescents with Asthma.
    Raissy HH; Kelly HW
    Paediatr Drugs; 2017 Dec; 19(6):533-538. PubMed ID: 28808948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of Asthma and Role of 2.5 µg Tiotropium Respimat
    Mansfield L; Duong-Quy S; Craig T
    Adv Ther; 2019 Oct; 36(10):2587-2599. PubMed ID: 31435830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tiotropium in the management of paediatric and adolescent asthma: Systematic review.
    Sunther M; Marchon K; Gupta A
    Paediatr Respir Rev; 2021 Jun; 38():58-62. PubMed ID: 33243704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiotropium – what role in asthma?
    Drug Ther Bull; 2015 Sep; 53(9):102-4. PubMed ID: 26358316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of muscarinic antagonists in asthma therapy.
    Cazzola M; Ora J; Rogliani P; Matera MG
    Expert Rev Respir Med; 2017 Mar; 11(3):239-253. PubMed ID: 28140686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tiotropium for the treatment of asthma in adolescents.
    Hamelmann E; Vogelberg C; Szefler SJ
    Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.
    Halpin DM; Kaplan AG; Russell RK
    Respir Med; 2017 Jul; 128():28-41. PubMed ID: 28610667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Once-daily tiotropium Respimat(®) 5 μg is an efficacious 24-h bronchodilator in adults with symptomatic asthma.
    Timmer W; Moroni-Zentgraf P; Cornelissen P; Unseld A; Pizzichini E; Buhl R
    Respir Med; 2015 Mar; 109(3):329-38. PubMed ID: 25661281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tiotropium in school-age children with moderate-to-severe symptomatic asthma: A systematic review.
    Rodrigo GJ; Neffen H
    Pediatr Allergy Immunol; 2017 Sep; 28(6):573-578. PubMed ID: 28692145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tiotropium for the Treatment of Asthma: Patient Selection and Perspectives.
    Chari VM; McIvor RA
    Can Respir J; 2018; 2018():3464960. PubMed ID: 29670674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tiotropium in asthma: From bench to bedside.
    Mansfield L; Bernstein JA
    Respir Med; 2019; 154():47-55. PubMed ID: 31212121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergics for asthma: a long history.
    Rodrigo GJ
    Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current long-acting muscarinic antagonists for the treatment of asthma.
    Ora J; Calzetta L; Ritondo BL; Matera MG; Rogliani P
    Expert Opin Pharmacother; 2021 Dec; 22(17):2343-2357. PubMed ID: 34219573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiotropium in children and adolescents with asthma.
    Murphy KR; Chipps BE
    Ann Allergy Asthma Immunol; 2020 Mar; 124(3):267-276.e3. PubMed ID: 31805357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III randomized controlled trial of tiotropium add-on therapy in children with severe symptomatic asthma.
    Szefler SJ; Murphy K; Harper T; Boner A; Laki I; Engel M; El Azzi G; Moroni-Zentgraf P; Finnigan H; Hamelmann E
    J Allergy Clin Immunol; 2017 Nov; 140(5):1277-1287. PubMed ID: 28189771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing Severe Asthma: A Role for the Long-Acting Muscarinic Antagonist Tiotropium.
    Hamelmann E
    Biomed Res Int; 2018; 2018():7473690. PubMed ID: 30474042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of tiotropium in children aged 1-5 years with persistent asthmatic symptoms: a randomised, double-blind, placebo-controlled trial.
    Vrijlandt EJLE; El Azzi G; Vandewalker M; Rupp N; Harper T; Graham L; Szefler SJ; Moroni-Zentgraf P; Sharma A; Vulcu SD; Sigmund R; Chawes B; Engel M; Bisgaard H
    Lancet Respir Med; 2018 Feb; 6(2):127-137. PubMed ID: 29361462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tiotropium Respimat®: A Review of Its Use in Asthma Poorly Controlled with Inhaled Corticosteroids and Long-Acting β2-Adrenergic Agonists.
    McKeage K
    Drugs; 2015 May; 75(7):809-16. PubMed ID: 25895466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and tolerability of once-daily tiotropium Respimat(®) as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis.
    Dahl R; Engel M; Dusser D; Halpin D; Kerstjens HAM; Zaremba-Pechmann L; Moroni-Zentgraf P; Busse WW; Bateman ED
    Respir Med; 2016 Sep; 118():102-111. PubMed ID: 27578478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of the efficacy and safety of once-daily tiotropium Respimat 2.5 micrograms in adults and adolescents with asthma.
    Meltzer EO; Berger WE
    Allergy Asthma Proc; 2018 Jan; 39(1):14-26. PubMed ID: 29279056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.